Queens Hospital Center
Jamaica, New York, 11432, United States
NCT Number: NCT05592860
The study is aimed to determine if a smartphone application based weekly glucose monitoring by a care provider is superior to the routine home glucose monitoring by patients in poorly controlled type 2 diabetes mellitus who are on insulin.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Jamaica, New York, 11432, United States
The study is a randomized, prospective cohort study. Subjects will be enrolled randomly after fulfilling the meeting criteria into two groups. Group 1 (intervention group) will used mobile application to enter their glucose level and group 2 (control group) will record their glucose level on daily diary. Data collection will be standardized in order to eliminate bias. In addition, all statistical analyses will be performed by a departmental statistician and not the study investigators. Patients in each arm of the study will be selected form the same population in order to avoid selection bias.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
participants in intervention group will use smart phone application and update glucose level and investigator will adjust the insulin accordingly
Other names: device related insulin adjustment
participants will use daily diary to record glucose level
Time frame: at the end of 3 months follow-up
A1C is a lab test that shows the average level of blood sugar (glucose) over the previous 3 months. It shows how well a person is controlling their blood sugar to help prevent complications from diabetes.
Time frame: baseline and 3 month
Change in weight
Time frame: baseline and 3 month
Change in BMI
Time frame: baseline and 3 month
Change in blood pressure - systolic and diastolic
Icahn School of Medicine at Mount Sinai
Other
Comparison of Glycemic Control With Smartphone Application (Vivovitals) - Based Glucose Monitoring to Routine Home Glucose Monitoring in Poorly Controlled T2DM Patients Treated With Insulin
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04083456
Amputation, Arterial Occlusive Diseases
Aurora, Colorado, United States
View Trial DetailsNCT05435157
Diabetes Mellitus, Endocrine System Diseases
Salamanca, Spain
View Trial DetailsNCT01934660
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04040634
Cardiovascular Diseases, Cognition Disorders
Maceió, Alagoas, Brazil
View Trial Details